AnYxis
Austria - ViennaBiotechnology
Focus: AnYxis is a private Austrian biotech focused on vaccines, antibody therapies, and immuno-oncological treatments targeting infectious diseases and oncology. The company operates at pre-revenue stage with an early-stage pipeline.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Open Jobs
0
About AnYxis
AI assessmentNot HiringNo open roles listed right now. Follow AnYxis to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
hu14.18-IL2
MelanomaOpen Jobs (0)
No open positions listed yet. Check their careers page directly.
Help build intelligence for AnYxis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.